Nureca Limited

Company Profile

Nureca Limited had its IPO on under the ticker symbol NURECA.

The company operates in the Healthcare sector and Medical Devices industry. Nureca Limited has a staff strength of 102 employees.

Stock update

Shares of Nureca Limited opened at ₹381.9 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹349 - ₹385.75, and closed at ₹352.3.

This is a -6.82% slip from the previous day's closing price.

A total volume of 6,222 shares were traded at the close of the day’s session.

In the last one week, shares of Nureca Limited have increased by +7.61%.

Nureca Limited's Key Ratios

Nureca Limited has a market cap of ₹3.26 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Nureca Limited’s revenue was ₹1.07 billion with a gross profit of ₹357.92 million and an EBITDA of ₹-135615008. The EBITDA ratio measures Nureca Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Nureca Limited’s operating margin was -13.59% while its return on assets stood at -5.11% with a return of equity of -4.15%.

In Q2, Nureca Limited’s quarterly earnings growth was a negative -93.7% while revenue growth was a negative 16.8%.

Nureca Limited’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹-4.88 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Nureca Limited’s profitability.

Nureca Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Nureca Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹2.07 billion

Total Liabilities

₹88.83 million

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

Nureca Limited ended 2024 with ₹2.07 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹2.07 billion while shareholder equity stood at ₹1.95 billion.

Nureca Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹88.83 million in other current liabilities, in common stock, ₹874.07 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹5.04 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

Nureca Limited’s total current assets stands at ₹1.87 billion while long-term investments were ₹0 and short-term investments were ₹1.34 billion. Its net receivables were ₹42.95 million compared to accounts payable of ₹49.90 million and inventory worth ₹344.77 million.

In 2024, Nureca Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Nureca Limited paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹352.3

52-Week High

₹1018.85

52-Week Low

₹294

Analyst Target Price

₹

Nureca Limited stock is currently trading at ₹352.3 per share. It touched a 52-week high of ₹1018.85 and a 52-week low of ₹1018.85. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹339.17 and 200-day moving average was ₹376.63 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 6298.3% of the company’s stock are held by insiders while 0% are held by institutions.